UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020

Clinical and experimental nephrology, 2021-12, Vol.25 (12), p.1292-1302

2021

Link zum Volltext

Verfügbarkeit prüfen

Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study

Clinical and experimental nephrology, 2020-06, Vol.24 (6), p.500-508

2020

Link zum Volltext

Verfügbarkeit prüfen

Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease

Clinical and experimental nephrology, 2022-06, Vol.26 (6), p.540-551

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

Scientific reports, 2022-10, Vol.12 (1), p.18056-18056, Article 18056

2022

Link zum Volltext

Verfügbarkeit prüfen

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes

Journal of Atherosclerosis and Thrombosis, 2021/05/01, Vol.28(5), pp.491-505

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of visceral fat area in patients with chronic kidney disease

Clinical and experimental nephrology, 2021-06, Vol.25 (6), p.608-620

2021

Link zum Volltext

Verfügbarkeit prüfen

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease

Internal Medicine, 2020/04/01, Vol.59(7), pp.971-976

2020

Link zum Volltext

Verfügbarkeit prüfen

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease

PloS one, 2020-11, Vol.15 (11), p.e0241626-e0241626

2020

Link zum Volltext

Verfügbarkeit prüfen

Machine learning for morbid glomerular hypertrophy

Scientific reports, 2022-11, Vol.12 (1), p.19155-19155, Article 19155

2022

Link zum Volltext

Verfügbarkeit prüfen

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment

Internal Medicine, 2019/01/01, Vol.58(1), pp.85-89

2019

Link zum Volltext

Verfügbarkeit prüfen

Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease

Hepatology international, 2021-06, Vol.15 (3), p.791-803

2021

Link zum Volltext

Verfügbarkeit prüfen

Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)

Clinical and experimental nephrology, 2018-10, Vol.22 (5), p.1079-1087

2018

Link zum Volltext

Verfügbarkeit prüfen

Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients

Clinical and experimental nephrology, 2019-08, Vol.23 (8), p.1022-1030

2019

Link zum Volltext

Verfügbarkeit prüfen

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes

Journal of Atherosclerosis and Thrombosis, 2021, Vol.28 (5), p.491-505

2021

Link zum Volltext

Verfügbarkeit prüfen

Germline Mutations for Kidney Volume in ADPKD

Kidney international reports, 2022-03, Vol.7 (3), p.537-546

2022

Link zum Volltext

Verfügbarkeit prüfen

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations

Journal of clinical medicine, 2020-01, Vol.9 (1), p.146

2020

Link zum Volltext

Verfügbarkeit prüfen

Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease

Stroke: vascular and interventional neurology, 2022-09, Vol.2 (5)

2022

Link zum Volltext

Verfügbarkeit prüfen

Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance (MGRS)

Kidney medicine, 2019-11, Vol.1 (6), p.397-401

2019

Link zum Volltext

Verfügbarkeit prüfen

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome

Kidney medicine, 2019-11, Vol.1 (6), p.391-396

2019

Link zum Volltext

Verfügbarkeit prüfen

Sex Differences in Time-Series Changes in Pseudo-R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis

Journal of personalized medicine, 2020-11, Vol.10 (4), p.248

2020

Link zum Volltext

Verfügbarkeit prüfen

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

Medicines (Basel, Switzerland), 2020-03, Vol.7 (3), p.13

2020

Link zum Volltext

Verfügbarkeit prüfen

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R2 Values in Relation to Renal Outcomes

Journal of clinical medicine, 2019-12, Vol.8 (12), p.2105

2019

Link zum Volltext

Verfügbarkeit prüfen

1. Antihypertensive Drug and Vasopressin Receptor Antagonist Treatment for Polycystic Kidney Disease

Nihon Naika Gakkai Zasshi, 2018/05/10, Vol.107(5), pp.834-840

2018

Link zum Volltext

Verfügbarkeit prüfen

Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD

Nephrology, dialysis, transplantation, 2024-05, Vol.39 (6), p.1008-1015

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Englisch
(45)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(31)
Urology & Nephrology
(18)
Kidney Diseases
(15)
Humans
(14)
Medicine
(11)
Medicine & Public Health
(10)
Nephrology
(10)
Patients
(10)
Prognosis
(10)
Polycystic Kidney
(9)
Urology
(9)
Female
(8)
General & Internal Medicine
(8)
Glomerular Filtration Rate
(8)
Medicine, General & Internal
(8)
Autosomal Dominant Polycystic Kidney Disease
(7)
Middle Aged
(7)
Mutation
(7)
Original Article
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020

Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study

Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes

Impact of visceral fat area in patients with chronic kidney disease

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease

Machine learning for morbid glomerular hypertrophy

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment

Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease

Elevation of the serum liver enzyme levels during tolvaptan treatment in patients with autosomal dominant polycystic kidney disease (ADPKD)

Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes

Germline Mutations for Kidney Volume in ADPKD

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations

Mutation Type and Intracranial Aneurysm Formation in Autosomal Dominant Polycystic Kidney Disease

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Proximal Tubulopathy With Fibrillary Inclusions: A Rare Manifestation of Lymphoma-Associated Monoclonal Gammopathy of Renal Significance (MGRS)

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome

Sex Differences in Time-Series Changes in Pseudo-R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R2 Values in Relation to Renal Outcomes

1. Antihypertensive Drug and Vasopressin Receptor Antagonist Treatment for Polycystic Kidney Disease

Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD

Suchergebnisse filtern